Skip to main content

PEN G SANDOZ (Sandoz Pty Ltd)

Product name
PEN G SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
173 working days (255)
Active ingredients
benzylpenicillin sodium
Registration type
New generic medicine
Indication
PEN G SANDOZ (powder for injection) is indicated for the treatment of infections caused by benzylpenicillin sensitive organisms. These include Streptococcus pyogenes and most other Gram-positive organisms. It is also indicated for the treatment of syphilis. Pen G Sandoz may also be used for the prevention of bacterial endocarditis in dental and upper respiratory tract procedures and prevention of wound infections and sepsis in surgical procedures where Streptococci are the likely pathogens.

Help us improve the Therapeutic Goods Administration site